Transforming growth factor-β synthesis by human peritoneal mesothelial cells: Induction by interleukin-1

American Journal of Pathology

Volumn 148, Issue 5, 1996, Pages 1679-1688

  Offner, Felix Albert ^a   Feichtinger, Hans ^a   Stadlmann, Sylvia ^a   Obrist, Peter ^a   Marth, Christian ^a   Klingler, Paul ^a   Grage, Birgit ^b   Schmahl, Marianne ^b   Knabbe, Cornelius ^b  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; MESSENGER RNA; RECOMBINANT GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 1BETA; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOASSAY; IMMUNOBLOTTING; INFLAMMATORY CELL; MESOTHELIUM CELL; PERITONEUM CELL; PRIORITY JOURNAL; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BASE SEQUENCE; BLOTTING, WESTERN; CELLS, CULTURED; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; EPITHELIUM; HUMANS; INTERFERON TYPE II; INTERLEUKIN-1; ISOMERISM; MOLECULAR SEQUENCE DATA; OMENTUM; PERITONEAL CAVITY; POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029983315     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Kutteh WH, Kutteh CC: Quantitation of tumor necrosis factor-α, interleukin-1-β and interleukin-6 in the effusions of ovarian epithelial neoplasms. Am J Obstet Gynecol 1992, 167:1864-1869
2. Propst T, Propst A, Herold M, Schauer G, Judmaier G, Braunsteiner H, Stoeffler G, Vogel W Spontaneous bacterial peritonitis is associated with high levels of interleukin-6 and its secondary mediators in ascitic fluid. Eur J Clin invest 1993, 23 832-836
3. Moradi MM, Carson LF, Weinberg B, Haney AF, Twiggs LB, Ramakrishnan S: Serum and ascitic fluid levels of interleukin-1, interleukin-6, and tumor necrosis factor-α in patients with ovarian epithelial cancer. Cancer 1993, 72:2433-2440
4. Scambia G, Testa U, Benedetti Panici P, Martucci R, Foti E, Petrini M, Amoroso M, Masciullo V, Peschle C, Manusco S. Interleukin-6 serum levels in patients with gynecological tumors Int J Cancer 1994, 57.318-323
5. Hirte HW, Clark DA Generation of lymphokine-activated killer cells in human ovarian carcinoma ascitic fluid, identification of transforming growth factor-β as a suppressive factor. Cancer Immunol Immunother 1991, 32.296-302
6. Wilson AP, Fox H, Scott IV, Lee H, Dent M, Golding PR: A comparison of the growth promoting properties of ascitic fluids, cyst fluids and peritoneal fluids from patients with ovarian tumours Br J Cancer 1991, 63:102-108
7. Tada T, Ohzeki S, Utsumi K, Takiuchi H, Muramatsu M, Li XF, Shimizu J, Fujiwara H, Hamaoka T: Transforming growth factor-β-induced inhibition of T cell function: susceptibility difference in T cells of various phenotypes and functions and its relevance to immunosuppression in the tumor-bearing state. J Immunol 1991, 146:1077-1082
8. Hirte HW, Clark DA, O'Connell G, Rusthoven J, Mazurka J. Reversal of suppression of lymphokine-activated killer cells by transforming growth factor-β in ovarian carcinoma ascitic fluid requires interleukin-2 combined with anti-CD3 antibody Cell Immunol 1992, 142.207-216
9. Massague J. The transforming growth factor-β family Annu Rev Cell Biol 1990, 6:597-641
10. Roberts AB, Sporn MB The Transforming Growth Factor βs. Peptide Growth Factors and Their Receptors. Edited by MB Sporn, AB Roberts. Heidelberg, Springer-Verlag, 1990, pp 419-472
11. Tucker RF, Shipley GD, Moses HL, Holley RW: Growth inhibitor from BSC-1 cells is closely related to the platelet type β transforming growth factor-β. Science 1984, 226:705-707
12. Knabbe C, Lippman ME, Wakefield LM, Flanders KC, Kasid A, Derynck R, Dickson RB. Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells. Cell 1987, 48:417-428
13. Marth C, Lang T, Koza A, Mayer I, Daxenbichler G: Transforming growth factor-β and ovarian carcinoma cells: regulation of proliferation and surface antigen expression. Cancer Lett 1990, 51 221-225
14. McCartney-Francis NL, Wahl SM. Transforming growth factor β: a matter of life and death. J Leukocyte Biol 1994, 55:401-409
15. Alexandrow MG, Moses HL: Transforming growth factor β and cell cycle regulation Cancer Res 1995, 55: 1452-1457
16. Mukai M, Shinkai K, Komatsu K, Akedo H Potentiation of invasive capacity of rat ascites hepatoma cells by transforming growth factor-β. Jpn J Cancer Res 1989, 80.107-110
17. Welch DR, Fabra A, Nakajima M Transforming growth factor β1 stimulates mammary adenocarcinoma cell invasion and metastatic potential Proc Natl Acad Sci USA 1990, 87:7678-7682
18. Jonjíc N, Peri G, Bernasconi S, Sciacca FL, Colotta F, Pelicci P, Lanfrancone L, Mantovani A Expression of adhesion molecules and chemotactic cytokines in cultured human mesothelial cells. J Exp Med 1992, 176: 1165-1174
19. Topley N, Brown Z, Joerres A, Westwick J, Davies M, Coles GA, Williams JD Human peritoneal mesothelial cells synthesize interleukin-8: synergistic induction by interleukin-1β and tumor necrosis factor-α. Am J Pathol 1993, 142.1876-1886
20. Topley N, Joerres A, Luttmann W, Petersen MM, Lang MJ, Thierauch KH, Muller C, Coles GA, Davies M, Williams JD: Human peritoneal mesothelial cells synthesize interleukin-6: induction by IL-1β and TNFα Kidney Int 1993, 43:226-233
21. Douvdevani A, Rapoport J, Konforty A, Argov S, Ovnat A, Chaimovitz C: Human peritoneal mesothelial cells synthesize IL-1α and β Kidney Int 1994, 46:993-1001
22. Zeillemaker AM, Mul FP, Hoynck van Papendrecht AA, Kuijpers TW, Roos D, Leguit P, Verbrugh HA: Polarized secretion of interleukin-8 by human mesothelial cells: a role in neutrophil migration. Immunology 1995, 84:227-232
23. Offner FA, Obrist P, Stadlmann S, Feichtinger H, Klinger P, Herold M, Zwierzina H, Hittmair A, Mikuz G, Abendstein B, Zeimet A, Marth C. IL-6 secretion by human peritoneal mesothelial and ovarian cancer cells. Cytokine 1995, 7.542-547
24. Li BY, Mohanraj D, Olson MC, Moradi M, Twiggs L, Carson LF, Ramakrishnan S Human ovarian epithelial cell cultures in vitro express both interleukin 1α and β genes Cancer Res 1992, 52:2248-2252
25. Wu S, Boyer CM, Whitaker RS, Berchuck A, Wiener JR, Weinberg JB, Bast RC Jr: Tumor necrosis factor-α as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumor cell proliferation and tumor necrosis factor-α expression. Cancer Res 1993, 53:1939-1944
26. Eischen A, Duclos B, Schmitt-Goguel M, Rouyer N, Bergerat JP, Hummel M, Oskam R, Oberling F. Human resident peritoneal macrophages: phenotype and biology Br J Haematol 1994, 88:712-722
27. Offner FA, Wirtz HC, Schiefer J, Bigalke I, Klosterhalfen B, Bittinger F, Mittermayer C, Kirkpatrick CJ. Interaction of human malignant melanoma (ST-ML-12) tumor spheroids with endothelial cell monolayers damage to endothelium by oxygen-derived free radicals. Am J Pathol 1992, 141 601-610
28. Rodeck U, Bossler A, Graeven U, Fox FE, Nowell PC, Knabbe C, Kari C: Transforming growth factor β production and responsiveness in normal melanocytes and melanoma cells Cancer Res 1994, 54:575-581
29. Maniatis T, Fritsch EF, Sambrook J: Molecular Cloning Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press, 1989
30. Derynck R, Jarrett JA, Chen EY, Eaton DH, Bell JR, Assoian RK, Roberts AB, Sporn MB, Goeddel DV Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells Nature 1985, 316:701-705
31. de Martin R, Haendler B, Hofer-Warbinek R, Gaugitsch H, Wrann M, Schlusener H, Seifert JM, Bodmer S, Fontana A, Hofer E: Complementary DNA for human glioblastoma-derived T cell suppressor factor, a novel member of the transforming growth factor-β gene family. EMBO J 1987, 6:3673-3677
32. Suggs SV, Wallace RB, Hirose T, Kawashima EH, Itakura K: Use of synthetic oligonucleotides as hybridization probes: isolation of cloned cDNA sequences for human β-2-microglobulin. Proc Natl Acad Sci USA 1981, 78:6613-6617
33. Gerwin BI, Lechner JF, Reddel RR, Roberts AB, Robbins KC, Gabrielson EW, Harris CC: Comparison of production of transforming growth factor-β and platelet-derived growth factor by normal human mesothelial cells and mesothelioma cell lines. Cancer Res 1987, 47:6180-6184
34. Maeda J, Ueki N, Ohkawa T, Iwahashi N, Nakano T, Hada T, Higashino K: Local production and localization of transforming growth factor-β in tuberculous pleurisy Clin Exp Immunol 1993, 92:32-38
35. Young SY, Thomas GJ, Stylianou E, Williams JD, Coles GA, Davies M: Source of peritoneal proteoglycans: human peritoneal mesothelial cells synthesize and secrete mainly small dermatan sulfate proteoglycans. Am J Pathol 1995, 146:520-529
36. Wahl SM, Hunt DA, Wakefield LM, McCartney-Francis N, Wahl LM, Robert AB, Sporn MB. Transforming growth factor type β induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci USA 1987, 84.5788-5792
37. Espevik T, Figari IS, Shalaby MR, Lackides GA, Lewis GD, Shepard HM, Palladino MA Jr: Inhibition of cytokine production by cyclosporin A and transforming growth factor β J Exp Med 1987, 166:571-576
38. Ranges GE, Figari IS, Espevik T, Palladino MA Jr: Inhibition of cytotoxic T cell development by transforming growth factor β and reversal by recombinant tumor necrosis factor α. J Exp Med 1987, 166:991-998
39. Gamble JR, Vadas MA: Endothelial adhesiveness for blood neutrophils is inhibited by transforming growth factor-β. Science 1988, 242.97-99
40. Tsunawaki SM, Sporn MB, Ding A, Nathan C: Deactivation of macrophages by transforming growth factor-β. Nature 1988, 334:260-262
41. Dubois CM, Ruscetti FW, Palaszynski EW, Falk LA, Oppenheim JJ, Keller JR: Transforming growth factor β is a potent inhibitor of interleukin 1 (IL-1) receptor expression proposed mechanism of inhibition of IL-1 action. J Exp Med 1990, 172.737-744
42. Turner M, Chantry D, Katsikis P, Berger A, Brennan GM, Feldmann M: Induction of the interleukin 1 receptor antagonist protein by transforming growth factor-β J Immunol 1991, 21:1635-1639
43. Muzio M, Sironi M, Polentarutti N, Mantovani A, Colotta F: Induction by transforming growth factor β1 of the interleukin-1 receptor antagonist and of its intracellular form in human polymorphonuclear cells. Eur J Immunol 1994, 24:3194-3198
44. Ulich TR, Yin S, Guo K, Yi ES, Remick D, del Castillo J. Intratracheal injection of endotoxin and cytokines II. Interleukin-6 and transforming growth factor β inhibit acute inflammation Am J Pathol 1991, 138.1097-1101
45. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D, Annunziata N, Doetschman T. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 1992, 359:693-699
46. Kulkarni AB, Huh CG, Becker D, Geiser A, Lyght M, Flanders KC Roberts AB, Sporn MB, Ward JM, Karlsson S: Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 1993, 90.770-774
47. Kulkarni AB, Ward JM, Yaswen L, Mackall CL, Bauer SR, Huh CG, Gress RE, Karlsson S: Transforming growth factor-β1 null mice: an animal model for inflammatory disorders. Am J Pathol 1995, 146:264-275
48. Sanderson N, Factor V, Nagy P, Kopp J, Kondaiah P, Wakefield L, Roberts AB, Sporn MB, Thorgeirsson SS: Hepatic expression of mature transforming growth factor β1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci USA 1995, 92:2572-2576
49. Ignotz RA, Massague J: Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 1986, 261:4337-4345
50. Williams RS, Rossi AM, Chegini N, Schultz G: Effect of transforming growth factor β on postoperative adhesion formation and intact peritoneum. J Surg Res 1992, 52 65-70
51. Davila RM, Crouch EC: Role of mesothelial and submesothelial stromal cells in matrix remodeling following pleural injury. Am J Pathol 1993, 142.547-555
52. Chegini N, Gold LI, Williams RS, Masterson BJ Localization of transforming growth factor β isoforms TGF-β1, TGF-β2, and TGF-β3 in surgically induced pelvic adhesions in the rat Obstet Gynecol 1994, 83:449-454
53. Kehrl JH, Roberts AB, Wakefield L, Jakowlew S, Sporn MB, Fauci A: Transforming growth factor is an important immunomodulatory protein for human B lymphocytes. J Immunol 1986, 137 3855-3860
54. Wahl SM, Hunt DA, Wong HL, Dougherty S, McCartney-Francis N, Wahl LM, Ellingsworth L, Schmidt JA. Hall G, Roberts AB, Sporn MB. Transforming growth factor β is a potent immunosuppressive agent which inhibits interleukin-1 dependent lymphocyte proliferation. J Immunol 1988, 140.3026-3032
55. Yanagihara K, Tsumuraya M: Transforming growth factor 1 induces apoptotic cell death in cultured human gastric carcinoma cells Cancer Res 1992, 52:4042-4045
56. Hurteau J, Rodriguez GC, Whitaker RS, Shah S, Mills G, Bast RC, Berchuck A: Transforming growth factor-β inhibits proliferation of human ovarian cancer cells obtained from ascites Cancer 1994, 74:93-99